pyridinoline has been researched along with Kahler Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrakis, MG; Katachanakis, C; Kyriakou, DS; Malliaraki, N; Margioris, AN; Passam, FH | 1 |
| Azaïs, I; Blanc, M; Brazier, M; Facon, T; Jamart, J; Jaubert, J; Kamel, S; Leleu, X; Mathiot, C; Samani, KK | 1 |
| Baccarani, M; Boni, P; Cangini, D; Cavo, M; Ceccolini, M; Cellini, C; Parente, R; Perrone, G; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E | 1 |
| Kapoor, S | 1 |
| Armbruster, FP; Horn, E; Karmatschek, M; Ludwig, H; Pecherstorfer, M; Seibel, MJ; Woitge, HW; Ziegler, R | 1 |
| Braun, HJ; Deicher, H; Fett, W; Harms, P; Kindler, U; Klinkenstein, C; Peest, D; Planker, M; Schäfer, E; Schumacher, K; Siecke, H | 1 |
| Cieslar, P; Hulejová, H; Klener, P; Slabý, J; Spacek, P; Spicka, I | 1 |
| Clark, RE; Durham, BH; Flory, AJ; Fraser, WD; Ion, EM; Woodcock, BE | 1 |
| Chrz, M; Cieslar, P; Hulejová, H; Klener, P; Procházka, B; Spacek, P; Spicka, I; Válková, V | 1 |
| Bayer, P; Diel, IJ; Horn, E; Keck, AV; Ludwig, H; Pecherstorfer, M; Seibel, MJ; Woitge, HW; Ziegler, R | 1 |
3 trial(s) available for pyridinoline and Kahler Disease
| Article | Year |
|---|---|
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Collagen Type I; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Pain; Peptides; Thalidomide; Treatment Outcome; Zoledronic Acid | 2006 |
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG).
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers, Tumor; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Paraneoplastic Syndromes; Peptides; Pilot Projects | 1996 |
[Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].
Topics: Adult; Aged; Amino Acids; Biomarkers; Bone Resorption; Clodronic Acid; Female; Humans; Male; Middle Aged; Multiple Myeloma | 1997 |
7 other study(ies) available for pyridinoline and Kahler Disease
| Article | Year |
|---|---|
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients.
Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Remodeling; Case-Control Studies; Collagen; Collagen Type I; Disease Progression; Female; Humans; Male; Multiple Myeloma; Neoplasm Staging; Osteocalcin; Osteolysis; Peptides; Severity of Illness Index | 2002 |
Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Topics: Aged; Amino Acids; Biomarkers; Bone Resorption; Collagen; Collagen Type I; Female; Humans; Male; Multiple Myeloma; Peptides; Predictive Value of Tests; Prognosis; Pyridinium Compounds; Retrospective Studies; Survival Analysis | 2005 |
TGF-beta 1 and urinary excretion of pyridinium crosslinks: Two often overlooked risk factors for assessing risk of progression in patients with monoclonal gammopathy of undetermined significance.
Topics: Amino Acids; Bone Resorption; Diagnosis, Differential; Disease Progression; Humans; Multiple Myeloma; Paraproteinemias; Risk Factors; Transforming Growth Factor beta1; Ultrasonography | 2008 |
Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Diseases; Bone Resorption; Breast Neoplasms; Female; Humans; Hyperparathyroidism; Integrin-Binding Sialoprotein; Middle Aged; Multiple Myeloma; Osteitis Deformans; Radioimmunoassay; Reference Values; Sialoglycoproteins | 1996 |
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Carmustine; Clodronic Acid; Combined Modality Therapy; Cytarabine; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoenzymes; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoclasts; Peptide Fragments; Podophyllotoxin; Procollagen; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2000 |
[Monitoring markers of bone turnover in multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Remodeling; Humans; Middle Aged; Multiple Myeloma; Osteocalcin; Paraproteinemias | 1999 |
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Humans; Integrin-Binding Sialoprotein; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Osteocalcin; Osteoporosis; Paraproteinemias; Prognosis; Radioimmunoassay; Sialoglycoproteins; Survival Analysis | 2001 |